Through our IP Culture® program, Fruent® assists pharmaceutical, biotechnology, and food technology companies with the knowledge to design and carry out comprehensive development strategies to bring successful products to market through risk-management strategies and process-driven commercialization. 

IP Strategy and Understanding IP Lifecycle Management

Fruent® assists companies demonstrate early efficacy by employing good laboratory practices (GLP), defined in medical product development regulations, for preclinical laboratory studies.

We help clients realize a structured environment around IP capture and commercialization, including:

• IP Assessment
• IP Strategy
• Lifecycle Risk Management
• Establishing an IP position
• Patent Harvesting
• Landscape Analysis – Current and Future